Please note that some translations using Google Translate may not be accurately represented, and image captions and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result for using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
A selection of articles from the Spring/Summer 2014 issue of Paths of Progress.
Download this issue for your iPad from iTunes
To see the entire publication, please
download the PDF version. If you'd like to receive a print version of
Paths of Progress in the mail, please
complete this form.
The discovery of a key protein, led by Gordon Freeman, PhD, may help spur therapies that make the body's immune system attack cancer cells.
How pathology helps guide and direct the precise course of treatment for patients at Dana-Farber/Brigham and Women's Cancer Center.
A new gene sequencing project sets its sights on the "exome" of tumor cells, potentially uncovering new treatment opportunities.
Clinical trials offer some patients new treatment options, but their real value lies in their potential to improve future therapies.
Posted on April 09, 2014
For all inquiries, call 617-632-4090 and ask to speak to a member of the media team. Please direct emails to email@example.com.
Request a Publication
Receive by mail the current issue of a Dana-Farber publication by completing this request form.